New advances in renal amyloidosis
- 1 April 2008
- journal article
- review article
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 12 (2) , 93-101
Abstract
Renal amyloidosis is a rare and intractable disease that accounts for 0.2% of the original kidney diseases of dialysis patients in Japan. However, the number of patients with renal amyloidosis seems to be increasing in recent years. There have been some new concepts focusing on the mechanism of amyloidogenesis, such as molecular chaperones, seeding mechanism, and genetic polymorphisms of precursor protein. Clinical and histological features of renal amyloidosis vary according to the type. Significantly higher levels of urinary protein excretion are seen in the AL type, whereas microscopic haematuria is more prominent in the AA type. Histologically, amyloid deposition of AL type has stronger predilection for GBM than mesangium, and spicule formation is more frequently observed. In contrast, AA type has a higher affinity to TBM and interstitial area. For the histological diagnosis of renal amyloidosis, plural staining methods including Congo-red, Daylon and thioflavin-T stains are available. Combinations of these staining methods are necessary for establishing the precise diagnosis. The more recent and intensive treatments for renal amyloidosis are expected to improve patient outcome. For AL amyloidosis, high-dose melphalan plus high-dose dexamethasone or VAD, in conjunction with bone marrow stem cells transplantation, have shown a definitive effect on reducing urinary protein excretion. The biological agent, tumor necrosis factor (TNFα) blocker, improves the renal function in AA-type renal amyloidosis, as well as suppresses the inflammatory reactions in patients with rheumatoid arthritis. Clinical advances have been made in various aspects of renal amyloidosis.Keywords
This publication has 72 references indexed in Scilit:
- Long-term mortality outcome in patients with reactive amyloidosis associated with rheumatoid arthritisClinical Rheumatology, 2005
- Relative transcriptional activities ofSAA1promoters polymorphic at position −13(T/C): Potential association between increased transcription and amyloidosisAmyloid, 2005
- Etanercept treatment of renal amyloidosis complicating rheumatoid arthritisInternal Medicine Journal, 2004
- Renal function at the time of renal biopsy as a predictor of prognosis in patients with primary AL-type amyloidosisClinical and Experimental Nephrology, 2004
- Fine‐needle aspiration of abdominal fat pad for amyloid detection: A clinically useful test?Diagnostic Cytopathology, 2004
- An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosisBone Marrow Transplantation, 2001
- Determination of IgA- and IgM-rheumatoid factors in patients with rheumatoid arthritis with and without nephropathy.Annals of the Rheumatic Diseases, 1996
- Immunological comparison of patients with rheumatoid arthritis with and without nephropathy.Annals of the Rheumatic Diseases, 1990
- Perimembranous-Type Renal Amyloidosis: A Peculiar Form of AL AmyloidosisNephron, 1989
- A histological study of hyaline deposits in laryngeal, aural, and nasal polyps and their differentiation from amyloidJournal of Clinical Pathology, 1964